Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages

Immunology and Cell Biology

Volumn 85, Issue 3, 2007, Pages 215-219

  Yoshida, Tsuyoshi ^a   Jones, Vickie C ^a   Kobayashi, Makiko ^a   Li, Xiao Dong ^b   Pollard, Richard B ^b   Suzuki, Fujio ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CCL2; HIV; Macrophages; Neutrophils

Indexed keywords

INTERLEUKIN 10; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; VIRUS REPLICATION;

CELLS, CULTURED; CHEMOKINE CCL2; HIV; HUMANS; INTERLEUKIN-10; MACROPHAGES; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, CCR5; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34247877684     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100024     Document Type: Article

References (37)

1. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter JM, Currier JS et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337: 725-733.
2. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734-739.
3. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
4. Walsh JC, Jones CD, Barnes EA, Gazzard BG, Mitchell SM. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS 1998; 12: 613-618.
5. Centers for Disease Control and Prevention HIV/AIDS surveillance report, no. 10. CDC: Atlanta, GA, 1999 p 38.
6. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997; 276: 960-964.
7. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387: 188-191.
8. + T cells using a combination of cytokines. J Exp Med 1998; 188: 83-91.
9. Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S et al. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002; 76: 707-716.
10. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233: 1089-1093.
11. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986; 233: 215-219.
12. Wahl SM, Orenstein JM. Immune stimulation and HIV-1 viral replication. J Leukoc Biol 1997; 62: 67-71.
13. Fan ST, Hsia K, Edgington TS. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood 1994; 84: 1567-1572.
14. Borghi MO, Panzeri P, Shattock R, Sozzani S, Dobrina A, Meroni PL. Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. Clin Exp Immunol 2000; 120: 93-100.
15. Devadas K, Hardegen NJ, Wahl LM, Hewlett IK, Clouse KA, Yamada KM et al. Mechanisms for macrophage-mediated HIV-1 induction. J Immunol 2004; 173: 6735-6744.
16. Rieckmann P, Poli G, Kehrl JH, Fauci AS. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J Exp Med 1991; 173: 1-5.
17. Ho WZ, Li YH, Zhu XH, Song L, Douglas SD. Induction of HIV-1 expression in chronically infected promonocytic cells cocultured with human lung fibroblasts. Clin Immunol Immunopathol 1996; 80: 171-178.
18. Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181: 1493-1505.
19. Gilles PN, Lathey JL, Spector SA. Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact. J Virol 1995; 69: 2133-2139.
20. Takei M, Kobayashi M, Li XD, Pollard RB, Suzuki F. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology 2005; 72: 117-123.
21. Sozzani S, Ghezzi S, Iannolo G, Luini W, Borsatti A, Polentarutti N et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 1998; 187: 439-444.
22. van Zandbergen G, Klinger M, Mueller A, Dannenberg S, Gebert A, Solbach W et al. Neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J Immunol 2004; 173: 6521-6525.
23. Liu G, Wu C, Wu Y, Zhao Y. Phagocytosis of apoptotic cells and immune regulation. Scand J Immunol 2006; 64: 1-9.
24. Vicenzi E, Alfano M, Ghezzi S, Gatti A, Veglia F, Lazzarin A et al. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1α, and MCP-3, and enhancement by MCP-1. J Leukoc Biol 2000; 68: 405-412.
25. Fantuzzi L, Spadaro F, Vallanti G, Canini I, Ramoni C, Vicenzi E et al. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood 2003; 102: 2334-2337.
26. Weissman D, Poli G, Fauci AS. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 442-449.
27. Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S et al. IL-10 cooperates with TNF-α to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 1996; 156: 841-851.
28. Takano S, Sami S, Majima T, Ishida N. Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascitic fluids of mice 2. 1-Methyladenosine isolated from cancer ascitic fluids enhances Listeria infection in mice. J Immunopharmacol 1986; 8: 59-73.
29. Kobayashi H, Kobayashi M, Heming TA, Bidani A, Pollard RB, Suzuki F. Cytokine production by rabbit alveolar macrophages: differences between activated and suppressor cell phenotypes. Immunol Lett 1999; 69: 339-346.
30. Montaner LJ, Griffin P, Gordon S. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro. J Gen Virol 1994; 75: 3393-3400.
31. Chang J, Naif HM, Li S, Jozwiak R, Ho-Shon M, Cunningham AL. The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res Hum Retroviruses 1996; 12: 1227-1235.
32. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004; 21: 215-226.
33. Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, Asjo B. In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 1991; 4: 751-759.
34. Mosborg-Petersen P, Toth FD, Zachar V, Villadsen JA, Norskov-Lauritsen N, Aboagye-Mathiesen G et al. Differential HIV replication and HIV-induced interferon production in mononuclear phagocytes: relationship to cell maturation. Res Virol 1991; 142: 353-361.
35. Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L et al. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J Virol 1994; 68: 1983-1986.
36. Sonza S, Maerz A, Deacon N, Meanger J, Mills J, Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996; 70: 3863-3869.
37. Yamashiro S, Kamohara H, Yoshimura T. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in maximal MCP-1 mRNA expression. J Leukoc Biol 1999; 65: 671-679.